This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. A combination of factors has led the FDA to provide consumers with this information. For more information about Delta-8 THC: CDC HEALTH ALERT NETWORK (HAN). exposures to any substance(s).
Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
WORCESTER —On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales , according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today.
This article was originally published on Analytical Cannabis and appears here with permission. . We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result.”.
FDA has wrongly mischaracterized these products as the same article as a prescription drug and has ignored, dismissed, and downplayed ample evidence that these full-spectrum hemp products can be marketed in a manner that is reasonably expected to be safe. “FDA In December 2019, CRN and FDA met to discuss these issues.
There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.
In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications. Note: The content on this page is for informational purposes only and is not intended to be professional medical advice.
The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.
After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Further information can be found at www.otcmarkets.com/learn/market-101. Since the year-end, the £2.6
Based on the data from the study, the breakdown of why U.S. When you put those findings together with data from High Yield Insights’ recent report , The CBD Consumer Experience (parts I and II), it’s much easier to understand what consumers want from CBD brands based on the 4 Ps of marketing: product, price, place, and promotion.
PEW Charitable Trusts has published the following article about cannabis use and employment law. Drug use can create workplace safety issues, he said. But employers should make an informed decision, he added. Thirty-seven states now allow adults to use marijuana medically, recreationally or both. Colorado state Sen.
Some issue broad tiers, others provide no information, and still others issue their cultivation licenses based on plant count. Here’s how the 282 acres stacked up by license type: Figuring out cultivation size nationally is probably more art than science given the data gaps that exist. View original article.
Those policy areas include public safety concerns, youth prevention, minority access to the industry, and national standards on product testing and pesticides. The group plans to compile data and research, and to release white papers on these policy issues that can be used to inform lawmakers. View original article.
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,
FDA stated in an April 3, 2019 Notice of Public Hearing that the agency is requesting and collecting “scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”
Orr further wrote that the company has been working with the FDA for 18 months and has provided more than enough information about their “cultivation, extraction, manufacturing, use and safety” of their proprietary FSHE. . View original article.
Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. He has spent his career working with and advising information companies in the compliance space. Cannacurio is a weekly column from Cannabiz Media featuring insights from the most comprehensive license data platform.
Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. He has spent his career working with and advising information companies in the compliance space. Cannacurio is a weekly column from Cannabiz Media featuring insights from the most comprehensive license data platform.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).
During the first seven weeks of the law’s enactment (with data collected from July 1 to August 20), reports show that there were 20 arrests in Chesterfield, two in Henrico, zero in Hanover and three in Richmond for a total of 25 arrests. Ignorance of the law isn’t a defense, so we encourage everyone to be both informed and safe.” .
Media outlets like Marijuana Business Daily , however, obtained more information from CannTrust and offer a more complete picture. Naturally, CannTrust expects a shortage, stating in their e-mail: “The Company is exploring options to mitigate product shortages and will keep you informed as soon as product becomes available.
The report, released this month, provides a wide array of data points detailing how legalization has affected law enforcement and marijuana use among Colorado residents. The report pulled data from the Healthy Kids Colorado Survey?—based View original article. This compares to increases in eating/drinking (35.2
This article was produced in partnership with PSI Labs. Cannabis legalization means consumers are more informed than ever—at least, theoretically. co-founder of Michigan testing firm PSI Labs , the results can get pretty gross—and it’s an issue that puts the safety of regulated cannabis into question. Inconsistent science.
Ability to meet the overall health needs of qualified patients and safety of the public. Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C.
Even the federal government is beginning to change course: Early this year, President Obama predicted that if enough states decriminalize marijuana, Congress might remove it from the list of Schedule I drugs, and he has informed officials in Washington and Colorado that the Justice Department will not prosecute anyone who complies with state laws.
The scientific content requires data stores far larger than news articles and thus we are encouraged by the architecture behind DASH drive. This is an excellent example of how free markets even in the face of prohibition still value safety and quality. Sequence data should be processed by end of week.
In this largely unregulated market, this first public comment action seems to be a genuine effort to allow the hemp industry to weigh in, so that the FDA would even have the necessary information to issue an NPRM. Also: Are there any currently used standardized definitions for the ingredients in cannabis products (e.g., hemp oil”)?
This article will walk you through what to look for when choosing a weed delivery service, so you can make the best choice for your needs. Prioritize Safety and Privacy When ordering weed online, safety and privacy should always be a concern. It’s also a good idea to check how they handle your personal information.
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. A total of 117 articles were retrieved for analysis, the majority of which were news stories for a physician audience.
The gaining acceptance of cannabis in a legal sense allows researchers to study and perform testing on cannabis in order to get a better understanding of its mechanisms, safety, and efficacy. The Study that Debunks the Lazy Stoner Stereotype. So why do people associate cannabis with being a lazy stoner? CBD is Shown to Help Improve Memory.
This move to sign HB 89 is in line with recently published data that shows autism spectrum disorder can be treated with cannabis safely and with favorable results. A recent study out of Israel looked at the safety and efficacy of cannabis and how administering CBD-heavy cannabis oil can help those with autism. . View original article.
The data, released Wednesday, showed the average price for one gram went from $6.83 It is important to note that the sample used to gather this information is rather small. The information about pricing before legalization is more in depth, coming from over 19,000 respondents. WeedAdvisor as Your Source for Information.
A new study recently published in the Journal of Adolescent Health collected data on 14,798 adolescents aged 12 to 17 who vaped weed or tobacco between December 2016 and January 2018. ” The study highlights concerns over the safety of cannabis vaping, but as a whole, it raises more questions than it answers.
“This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission—public health, public safety and equity, among others—front of mind.”. View original article.
Data & Software. This ensures that at any moment data can be sourced from every legal cannabis plant that has been grown and sold. Seed-to-sale data is powerful in that it allows companies to be mindful of product inventory and recall items when necessary.
With this information, recreational cannabis consumers can make more well-informed choices regarding the activities they engage in post-consumption (e.g., Furthermore, the data can be utilized to update laws that reflect the truth surrounding cannabis impairment more accurately. operating a motor vehicle).
The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”.
This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. Over time, Maryland has refined its approach to ensure the accessibility and safety of MMJ for its residents.
The AHA position paper then moves on to address a range of known, potential, and suggested safety concerns associated with cannabis use. For a more detailed look at the current state of research on the subject, refer to CannaMD ‘s article: Marijuana & Pregnancy: Top Studies. ACUTE EFFECTS OF MARIJUANA. for men, 1.3%
In this article, we aim to clarify how the MMJ telemedicine process works, examining their advantages, challenges, legal implications, and future potential. Legal frameworks aim to ensure patient safety, privacy, and quality of care while adapting to technological advancements. Encryption ensures patient data security.
You cannot read a cannabis industry newsletter these days without seeing articles that hype the future impact of New York, New Jersey, Virginia, and New Mexico adult use programs. Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. View original article.
Medical professionals want more information about medicinal cannabis before they start prescribing it to patients, a new study has found. Screening for relevancy, full-text review, data extraction, and risk of bias were completed by two independent investigators. Pre-defined inclusion and exclusion criteria were applied uniformly.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content